Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
- PMID: 40580476
- DOI: 10.1016/j.celrep.2025.115907
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters
Abstract
We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stabilize with each booster, T cell responses quickly plateau and remain stable. Notably, approximately 30% of participants show evidence suggestive of asymptomatic infections. Single-cell RNA sequencing reveals a diverse and stable landscape of spike-specific T cell phenotypes without signs of exhaustion or functional impairment. Individuals with evidence of asymptomatic infection display increased frequencies of Th17-like CD4+ T cells and GZMKhi/IFNR+ CD8+ T cell subsets. In this group, repeated vaccinations correlate with an increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections.
Keywords: COVID-19; CP: Immunology; SARS-CoV-2; T cell responses; antibody responses; asymptomatic infection; booster vaccination; exhaustion; mRNA vaccines; scRNA-seq.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests A.S. is a consultant for Darwin Health, EmerVax, Gilead Sciences, Guggenheim Securities, RiverVest Venture Partners, and Arcturus. D.W. is a consultant for Moderna. S.C. has consulted for GSK, JP Morgan, Citi, Morgan Stanley, Avalia NZ, Nutcracker Therapeutics, University of California, California State Universities, United Airlines, Adagio, and Roche. LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work.
Update of
-
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.bioRxiv [Preprint]. 2025 Jan 9:2025.01.08.631842. doi: 10.1101/2025.01.08.631842. bioRxiv. 2025. Update in: Cell Rep. 2025 Jul 22;44(7):115907. doi: 10.1016/j.celrep.2025.115907. PMID: 39829792 Free PMC article. Updated. Preprint.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
